Biosimilar use and switching in belgium: avenues for integrated policymaking

HIGHLIGHTS

  • who: Policymaking and collaborators from the Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium, Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, Netherlands State University of Campinas, Brazil have published the article: Biosimilar Use and Switching in Belgium: Avenues for Integrated Policymaking, in the Journal: (JOURNAL)
  • what: The study set-up and aims were explained.
  • how: In the second part participants were asked to indicate their level of agreement with various statements on a 5-point Likert scale Frontiers in Pharmacology | www.frontiersin.org 2.4.2 Group Discussions A structured discussion . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?